| Scott W Haesemeyer, MD | |
|
12300 Metcalf Ave, Overland Park, KS 66213-1324 | |
| (913) 317-7000 | |
| Not Available |
| Full Name | Scott W Haesemeyer |
|---|---|
| Gender | Male |
| Speciality | Diagnostic Radiology |
| Experience | 28 Years |
| Location | 12300 Metcalf Ave, Overland Park, Kansas |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1326068149 | NPI | - | NPPES |
| Facility Name | Location | Facility Type |
|---|---|---|
| Saint Luke's South Hospital | Overland park, KS | Hospital |
| Overland Park Reg Med Ctr | Overland park, KS | Hospital |
| Saint Lukes North Hospital | Kansas city, MO | Hospital |
| Belton Regional Medical Center | Belton, MO | Hospital |
| Anderson County Hospital | Garnett, KS | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Advanced Radiology Consultants Of Kansas City Pa | 0042645947 | 38 |
| Advanced Radiology Consultants Of Kansas City Pa | 0042645947 | 38 |
News Archive
Forest Laboratories, Inc. (NYSE:FRX) today announced the publication of data from its pivotal Phase III Study of an Investigational Fixed-Dose Combination (FDC) of nebivolol and valsartan in the May 30, 2014 issue of The Lancet.
Just as hurricanes in the Gulf states and Guatemala have raised the risks of cholera outbreaks, researchers at Harvard Medical School have identified a new type of antibiotic against the cholera bacteria.
Treatment with three relatively new "targeted" cancer drugs has been linked to a slightly elevated chance of fatal side effects, according to a new analysis led by scientists at Dana-Farber Cancer Institute. They added that the risk remains low, but should be taken into account by physicians and patients.
The U.S. District Court for the Western District of Texas has issued a decision in the patent litigation between Kinetic Concepts, Inc. Wake Forest University and Smith & Nephew, Inc. The Court held that the patent claims licensed by KCI from Wake Forest University and asserted in this litigation are invalid.
Vaccines that induce protective T-cell responses could protect against members across the filovirus family, according to a study published February 28 in the open-access journal PLOS Pathogens by Tomáš Hanke of the University of Oxford, Bette Korber of the Los Alamos National Laboratory, and colleagues.
› Verified 4 days ago
| Entity Name | Saint Lukes Physician Group Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1093263717 PECOS PAC ID: 3577476894 Enrollment ID: O20031111000818 |
News Archive
Forest Laboratories, Inc. (NYSE:FRX) today announced the publication of data from its pivotal Phase III Study of an Investigational Fixed-Dose Combination (FDC) of nebivolol and valsartan in the May 30, 2014 issue of The Lancet.
Just as hurricanes in the Gulf states and Guatemala have raised the risks of cholera outbreaks, researchers at Harvard Medical School have identified a new type of antibiotic against the cholera bacteria.
Treatment with three relatively new "targeted" cancer drugs has been linked to a slightly elevated chance of fatal side effects, according to a new analysis led by scientists at Dana-Farber Cancer Institute. They added that the risk remains low, but should be taken into account by physicians and patients.
The U.S. District Court for the Western District of Texas has issued a decision in the patent litigation between Kinetic Concepts, Inc. Wake Forest University and Smith & Nephew, Inc. The Court held that the patent claims licensed by KCI from Wake Forest University and asserted in this litigation are invalid.
Vaccines that induce protective T-cell responses could protect against members across the filovirus family, according to a study published February 28 in the open-access journal PLOS Pathogens by Tomáš Hanke of the University of Oxford, Bette Korber of the Los Alamos National Laboratory, and colleagues.
› Verified 4 days ago
| Entity Name | Advanced Radiology Consultants Of Kansas City Pa |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1447800131 PECOS PAC ID: 0042645947 Enrollment ID: O20200130002086 |
News Archive
Forest Laboratories, Inc. (NYSE:FRX) today announced the publication of data from its pivotal Phase III Study of an Investigational Fixed-Dose Combination (FDC) of nebivolol and valsartan in the May 30, 2014 issue of The Lancet.
Just as hurricanes in the Gulf states and Guatemala have raised the risks of cholera outbreaks, researchers at Harvard Medical School have identified a new type of antibiotic against the cholera bacteria.
Treatment with three relatively new "targeted" cancer drugs has been linked to a slightly elevated chance of fatal side effects, according to a new analysis led by scientists at Dana-Farber Cancer Institute. They added that the risk remains low, but should be taken into account by physicians and patients.
The U.S. District Court for the Western District of Texas has issued a decision in the patent litigation between Kinetic Concepts, Inc. Wake Forest University and Smith & Nephew, Inc. The Court held that the patent claims licensed by KCI from Wake Forest University and asserted in this litigation are invalid.
Vaccines that induce protective T-cell responses could protect against members across the filovirus family, according to a study published February 28 in the open-access journal PLOS Pathogens by Tomáš Hanke of the University of Oxford, Bette Korber of the Los Alamos National Laboratory, and colleagues.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Scott W Haesemeyer, MD 8000 W 110th St, Ste 150, Overland Park, KS 66210-2382 Ph: (913) 599-6777 | Scott W Haesemeyer, MD 12300 Metcalf Ave, Overland Park, KS 66213-1324 Ph: (913) 317-7000 |
News Archive
Forest Laboratories, Inc. (NYSE:FRX) today announced the publication of data from its pivotal Phase III Study of an Investigational Fixed-Dose Combination (FDC) of nebivolol and valsartan in the May 30, 2014 issue of The Lancet.
Just as hurricanes in the Gulf states and Guatemala have raised the risks of cholera outbreaks, researchers at Harvard Medical School have identified a new type of antibiotic against the cholera bacteria.
Treatment with three relatively new "targeted" cancer drugs has been linked to a slightly elevated chance of fatal side effects, according to a new analysis led by scientists at Dana-Farber Cancer Institute. They added that the risk remains low, but should be taken into account by physicians and patients.
The U.S. District Court for the Western District of Texas has issued a decision in the patent litigation between Kinetic Concepts, Inc. Wake Forest University and Smith & Nephew, Inc. The Court held that the patent claims licensed by KCI from Wake Forest University and asserted in this litigation are invalid.
Vaccines that induce protective T-cell responses could protect against members across the filovirus family, according to a study published February 28 in the open-access journal PLOS Pathogens by Tomáš Hanke of the University of Oxford, Bette Korber of the Los Alamos National Laboratory, and colleagues.
› Verified 4 days ago
Dr. Michael Farber, MD Radiology Medicare: Accepting Medicare Assignments Practice Location: 6650 W 110th St Ste 100, Overland Park, KS 66211 Phone: 913-344-9989 Fax: 913-344-9957 | |
Dr. Jeffrey Ralph Conaway, MD Radiology Medicare: Accepting Medicare Assignments Practice Location: 5721 W 119th St, Overland Park, KS 66209 Phone: 913-498-7363 Fax: 913-498-6699 | |
Dr. Chad M Ruble, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: 8000 W 110th St, Suite 150, Overland Park, KS 66210 Phone: 913-599-6777 Fax: 913-599-3955 | |
Kimberly Wherry-roys, MD Radiology Medicare: Accepting Medicare Assignments Practice Location: 9100 W 74th St, Overland Park, KS 66204 Phone: 913-676-2310 | |
Dr. Susanne Marie Chow, MD Radiology Medicare: Accepting Medicare Assignments Practice Location: 5721 W 119th St, Overland Park, KS 66209 Phone: 913-498-7164 Fax: 913-498-7899 | |
Dr. Michael A Hughes, MD Radiology Medicare: Accepting Medicare Assignments Practice Location: 5721 W 119th St, Overland Park, KS 66209 Phone: 913-498-7409 Fax: 913-498-7470 | |
Samuel Joseph Hund, Radiology Medicare: Accepting Medicare Assignments Practice Location: 6650 W 110th St Ste 200, Overland Park, KS 66211 Phone: 913-319-8400 |